CY1118742T1 - Μεθοδος για την παρασκευη ναλτρεξονης - Google Patents

Μεθοδος για την παρασκευη ναλτρεξονης

Info

Publication number
CY1118742T1
CY1118742T1 CY20171100341T CY171100341T CY1118742T1 CY 1118742 T1 CY1118742 T1 CY 1118742T1 CY 20171100341 T CY20171100341 T CY 20171100341T CY 171100341 T CY171100341 T CY 171100341T CY 1118742 T1 CY1118742 T1 CY 1118742T1
Authority
CY
Cyprus
Prior art keywords
naltrexon
preparing
morphinan
dihydroxy
epoxy
Prior art date
Application number
CY20171100341T
Other languages
Greek (el)
English (en)
Inventor
Faveri Carla De
Florian Anton Martin Huber
Mariano Stivanello
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of CY1118742T1 publication Critical patent/CY1118742T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY20171100341T 2010-11-05 2017-03-17 Μεθοδος για την παρασκευη ναλτρεξονης CY1118742T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41040510P 2010-11-05 2010-11-05
DKPA201001007 2010-11-05
US201161489701P 2011-05-25 2011-05-25
DKPA201100396 2011-05-25
PCT/DK2011/000128 WO2012059103A1 (en) 2010-11-05 2011-11-04 Method for the manufacturing of naltrexone

Publications (1)

Publication Number Publication Date
CY1118742T1 true CY1118742T1 (el) 2017-07-12

Family

ID=45001588

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100341T CY1118742T1 (el) 2010-11-05 2017-03-17 Μεθοδος για την παρασκευη ναλτρεξονης

Country Status (20)

Country Link
EP (1) EP2635586B1 (enExample)
JP (2) JP6246589B2 (enExample)
AP (1) AP3415A (enExample)
AU (1) AU2011325563B2 (enExample)
CA (1) CA2815093C (enExample)
CY (1) CY1118742T1 (enExample)
DK (1) DK2635586T3 (enExample)
EA (1) EA022266B1 (enExample)
ES (1) ES2620660T3 (enExample)
HR (1) HRP20170379T1 (enExample)
HU (1) HUE033596T2 (enExample)
LT (1) LT2635586T (enExample)
ME (1) ME02621B (enExample)
MX (1) MX2013005009A (enExample)
PL (1) PL2635586T3 (enExample)
PT (1) PT2635586T (enExample)
RS (1) RS55777B1 (enExample)
SI (1) SI2635586T1 (enExample)
SM (1) SMT201700177T1 (enExample)
WO (1) WO2012059103A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005217A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
AR096851A1 (es) 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno
AU2014368548B2 (en) 2013-12-20 2019-09-19 H. Lundbeck A/S Use of an opioid receptor antagonist with kappa-activity and vortioxetine for treatment of depressive disorder with melancholic features
MX2016013889A (es) 2014-04-22 2017-03-09 Otsuka Pharma Co Ltd Medicamento.
US9701688B2 (en) * 2014-05-05 2017-07-11 Noramco, Inc. Process for the preparation of opioid compounds
US9701687B2 (en) * 2014-05-05 2017-07-11 Noramco, Inc. Process for the preparation of opioid compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
ATE178329T1 (de) * 1989-10-16 1999-04-15 Us Health Totale synthese von northebain-, normorphin-, noroxymorphon-enantiomeren und -derivaten via n- nor-zwischenverbindungen
FR2906252B1 (fr) 2006-09-21 2008-11-28 Sanofi Aventis Sa Procede de preparation d'halogenures de n-aklyl naltrexone
WO2008138383A1 (de) 2007-05-16 2008-11-20 Cilag Ag Verfahren zur herstellung von n-methylnaltrexonbromid
ES2566559T3 (es) 2008-09-30 2016-04-13 Mallinckrodt Llc Procesos para la alquilación de grupos amino secundarios de derivados de morfinano
JP5794980B2 (ja) 2009-05-25 2015-10-14 ハー・ルンドベック・アクチエゼルスカベット ナルトレキソンからの塩酸ナルメフェンの調製

Also Published As

Publication number Publication date
AU2011325563A1 (en) 2013-05-02
DK2635586T3 (en) 2017-03-27
JP2016199566A (ja) 2016-12-01
ME02621B (me) 2017-06-20
EP2635586B1 (en) 2017-02-08
JP6246589B2 (ja) 2017-12-13
AP3415A (en) 2015-09-30
SMT201700177T1 (it) 2017-05-08
MX2013005009A (es) 2013-08-01
RS55777B1 (sr) 2017-07-31
ES2620660T3 (es) 2017-06-29
AU2011325563B2 (en) 2015-08-20
HUE033596T2 (hu) 2017-12-28
PL2635586T3 (pl) 2017-06-30
EP2635586A1 (en) 2013-09-11
HRP20170379T1 (hr) 2017-05-05
JP2013541564A (ja) 2013-11-14
JP6215399B2 (ja) 2017-10-18
AP2013006897A0 (en) 2013-05-31
SI2635586T1 (sl) 2017-07-31
LT2635586T (lt) 2017-04-10
EA022266B1 (ru) 2015-11-30
EA201390658A1 (ru) 2013-11-29
WO2012059103A1 (en) 2012-05-10
CA2815093C (en) 2019-08-06
CA2815093A1 (en) 2012-05-10
PT2635586T (pt) 2017-03-30

Similar Documents

Publication Publication Date Title
CY1118742T1 (el) Μεθοδος για την παρασκευη ναλτρεξονης
MX374397B (es) Metodo de produccion para tagatosa.
GB201103836D0 (en) Conjugation process
MY167697A (en) Method for producing 4,4-difluoro-3,4- dihydroisoquinoline derivatives
MX2015016835A (es) Metodo para reticular acido hialuronico; metodo para preparar un hidrogel inyectable; el hidrogel obtenido; el uso del hidrogel obtenido.
IN2014CN04160A (enExample)
EP2980090A4 (en) PROCESS FOR THE PREPARATION OF (1S, 4S, 5S -4-BROM-6-OXABICYCLO [3.2.1] OCTAN-7-ON
CO7220321A2 (es) Método para producir un aditivo así como carbonato de calcio a partir de agregado de concreto así como un dispositivo para realizar el procedimiento
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
EA201500234A1 (ru) Способ получения бензоксазинонов
IN2014CN03197A (enExample)
FR3012137B1 (fr) Procede de production de composes fluores
MX376491B (es) Metodo para producir 4-hidroxi-4-metil-tetrahidropiranos 2-sustituidos, donde dicho proceso usa reciclado.
MX376905B (es) Metodo para preparar bifenilaminas a partir de azobencenos mediante catalisis de rutenio.
CY1118785T1 (el) Διαδικασια για την ανακτηση υδροχλωρικης ναλμεφενης
PH12013501708B1 (en) Commercial scale process for production of prrsv
UA117849C2 (uk) Спосіб одержання 3-заміщених складних ефірів (індол-1-іл)-оцтової кислоти
CY1117407T1 (el) Διαχωρισμος των εναντιομερων παραγωγων τριαζινης με χρηση τρυγικου οξεος
CL2008003065A1 (es) Proceso para preparar un compuesto derivado de acido carbamoil-fosfonico o del acido carbamoil-fosfinico.
MX2014003936A (es) Procedimiento para preparar ditiina-tetracarboximidas.
NZ710106A (en) A fungicidal composition
SG11201908724VA (en) Method for producing acetic acid
JO3209B1 (ar) طريقة لتصنيع نالتريكسون
MX2013002395A (es) Procedimiento de preparacion de ditiin-tetracarboximidas.
ECSP13012660A (es) Método para la elaboración de naltrexona